씨엔알리서치

359090KOSDAQ

65.3 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment21.3 / 25

Momentum14.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Slightly up 4.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

CNR Research, established in 1997 as Korea's first CRO, provides clinical trial services for drug development, including Phase I-III trials for regulatory approval and post-market studies (PMS/Phase IV). It maintains the top position among domestic CROs by revenue in 2023 and aims to expand globally through IT solution development and oncology trial expertise.

Number of Employees

522people

Average Salary

58.3M KRW

Score Calculation Basis

Detailed Financial Score

PER

44.02Industry Average 15.000.0Point

2.9x industry avg (risky)

PBR

0.48Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

2.15Industry Average 8.001.0Point

Well below industry avg

Debt Ratio

5.27Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.6% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼51.8% (2-year basis)

ROE Trend

2.0 / 4

Avg ROE 7.9% (declining, 3yr)

Detailed News Sentiment

5 totalPositive 5Neutral 0Negative 0Average Sentiment Score 85

Positive
"씨엔알리서치, 글로벌 빅파마들의 한국 투자 본격화 등 수혜 기대"
씨엔알리서치의 실적 개선 전망이 긍정적으로 평가되어 주가 상승 기대가 높아짐.
Positive
씨엔알리서치, ‘RBQM 시대의 임상 데이터 관리’ 웨비나 개최
씨엔알리서치가 글로벌 규제 변화에 대응하는 RBQM 데이터 관리 웨비나 개최로 인해 전문성 강화 및 시장 경쟁력 향상 기대.
Positive
씨엔알리서치, 2분기 흑자 전환...글로벌 임상 수주 확대
씨엔알리서치의 2분기 흑자 전환은 CRO 부문 성장과 해외 수주 확대로 긍정적 영향을 받았다.

Detailed Momentum

52-week position8.0Point

Near 52w high (97%, uptrend)

Current 1,981Won52-week high 2,01552-week low 511

1-month return4.0Point

1m +4.48% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14